TriSalus Life Sciences holds annual stockholder meeting

• TriSalus Life Sciences held its annual stockholder meeting on May 14, 2026.
• Stockholders ratified appointment of Grant Thornton as independent registered accounting firm for fiscal year ending Dec. 31, 2026.
• Advisory vote backed holding future stockholder advisory votes on named executive officer compensation every three years.
• Board later adopted a resolution to hold those advisory votes every three years; document does not indicate any further implementation steps beyond that decision.
• Advisory vote on compensation of named executive officers was also approved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-035068), on May 14, 2026, and is solely responsible for the information contained therein.